IL261265A - Peptide inhibitors of calcium channels - Google Patents
Peptide inhibitors of calcium channelsInfo
- Publication number
- IL261265A IL261265A IL261265A IL26126518A IL261265A IL 261265 A IL261265 A IL 261265A IL 261265 A IL261265 A IL 261265A IL 26126518 A IL26126518 A IL 26126518A IL 261265 A IL261265 A IL 261265A
- Authority
- IL
- Israel
- Prior art keywords
- calcium channels
- peptide inhibitors
- peptide
- inhibitors
- calcium
- Prior art date
Links
- 108090000312 Calcium Channels Proteins 0.000 title 1
- 102000003922 Calcium Channels Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662298204P | 2016-02-22 | 2016-02-22 | |
| PCT/US2017/018840 WO2017147128A1 (en) | 2016-02-22 | 2017-02-22 | Peptide inhibitors of calcium channels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL261265A true IL261265A (en) | 2018-10-31 |
Family
ID=59685595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL261265A IL261265A (en) | 2016-02-22 | 2018-08-21 | Peptide inhibitors of calcium channels |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10894811B2 (enExample) |
| EP (1) | EP3419994B1 (enExample) |
| JP (1) | JP2019512216A (enExample) |
| AU (1) | AU2017222450A1 (enExample) |
| BR (1) | BR112018017144A2 (enExample) |
| ES (1) | ES2979122T3 (enExample) |
| IL (1) | IL261265A (enExample) |
| MX (1) | MX2018010132A (enExample) |
| WO (1) | WO2017147128A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3554527A1 (en) * | 2016-12-13 | 2019-10-23 | Spyryx Biosciences, Inc. | Saline formulations of splunc1 peptides |
| WO2022204185A1 (en) * | 2021-03-22 | 2022-09-29 | The University Of North Carolina At Chapel Hill | Modified peptidomimetics and methods of use |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3023787A1 (de) | 1980-06-25 | 1982-01-21 | Studiengesellschaft Kohle mbH, 4330 Mülheim | Verfahren zur erhoehung der inkorporation und der expression von genetischem material in die kerne von intakten zellen mit hilfe von liposomen |
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US4501729A (en) | 1982-12-13 | 1985-02-26 | Research Corporation | Aerosolized amiloride treatment of retained pulmonary secretions |
| US4957735A (en) | 1984-06-12 | 1990-09-18 | The University Of Tennessee Research Corporation | Target-sensitive immunoliposomes- preparation and characterization |
| JP2627899B2 (ja) | 1987-08-19 | 1997-07-09 | 株式会社 ビタミン研究所 | 遺伝子封入リポソームの製法 |
| US5354844A (en) | 1989-03-16 | 1994-10-11 | Boehringer Ingelheim International Gmbh | Protein-polycation conjugates |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5693622A (en) | 1989-03-21 | 1997-12-02 | Vical Incorporated | Expression of exogenous polynucleotide sequences cardiac muscle of a mammal |
| EP0452457B1 (en) | 1989-11-03 | 1997-08-20 | Vanderbilt University | Method of in vivo delivery of functioning foreign genes |
| FR2715847B1 (fr) | 1994-02-08 | 1996-04-12 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucléiques, préparation et utilisations. |
| FR2730637B1 (fr) | 1995-02-17 | 1997-03-28 | Rhone Poulenc Rorer Sa | Composition pharmaceutique contenant des acides nucleiques, et ses utilisations |
| CA2264482A1 (en) | 1996-09-06 | 1998-03-12 | The Trustees Of The University Of Pennsylvania | An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
| CA2271325A1 (en) | 1996-11-12 | 1998-05-22 | The Regents Of The University Of California | Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery |
| US20040110938A1 (en) * | 2000-02-24 | 2004-06-10 | Parekh Rajesh Bhikhu | Proteins, genes and their use for diagnosis and treatment of schizophrenia |
| ATE255229T1 (de) * | 2000-02-24 | 2003-12-15 | Oxford Glycosciences Uk Ltd | Dpi-6, ein therapeutischer biomarker in neurologischen krankheiten |
| US20050192221A1 (en) * | 2003-12-04 | 2005-09-01 | Mccray Paul B.Jr. | Methods and compositions related to plunc polypeptides |
| DE102004031579B4 (de) * | 2004-06-29 | 2012-12-27 | Forschungsverbund Berlin E.V. | Peptide zur Inhibition der Interaktion von Proteinkinase A und Proteinkinase A-Ankerproteinen, diese umfassendes Nukleinsäuremolekül, Vektor, Wirtszelle, gegen diese gerichtetes Erkennungsmolekül, diese enthaltende pharmazeutische Zusammensetzung, diese enthaltender Kit und deren Verwendung |
| BR112014006535A2 (pt) * | 2011-09-20 | 2017-03-28 | Univ North Carolina Chapel Hill | regulação dos canais de sódio através das proteínas plunc |
-
2017
- 2017-02-22 JP JP2018544213A patent/JP2019512216A/ja active Pending
- 2017-02-22 ES ES17757105T patent/ES2979122T3/es active Active
- 2017-02-22 BR BR112018017144A patent/BR112018017144A2/pt not_active IP Right Cessation
- 2017-02-22 EP EP17757105.6A patent/EP3419994B1/en active Active
- 2017-02-22 US US16/078,397 patent/US10894811B2/en active Active
- 2017-02-22 WO PCT/US2017/018840 patent/WO2017147128A1/en not_active Ceased
- 2017-02-22 AU AU2017222450A patent/AU2017222450A1/en not_active Abandoned
- 2017-02-22 MX MX2018010132A patent/MX2018010132A/es unknown
-
2018
- 2018-08-21 IL IL261265A patent/IL261265A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US10894811B2 (en) | 2021-01-19 |
| BR112018017144A2 (pt) | 2019-01-15 |
| ES2979122T3 (es) | 2024-09-24 |
| EP3419994B1 (en) | 2024-05-08 |
| AU2017222450A1 (en) | 2018-09-27 |
| JP2019512216A (ja) | 2019-05-16 |
| EP3419994A1 (en) | 2019-01-02 |
| EP3419994C0 (en) | 2024-05-08 |
| EP3419994A4 (en) | 2019-11-06 |
| US20190062386A1 (en) | 2019-02-28 |
| WO2017147128A1 (en) | 2017-08-31 |
| MX2018010132A (es) | 2019-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL321844A (en) | Menin–MLL interaction inhibitors | |
| ZA201805879B (en) | Inhibitors of wdr5 protein-protein binding | |
| IL259560A (en) | Inhibitors of the menin-mll interaction | |
| IL256221B (en) | Hydantoin containing deoxyuridine triphosphatase inhibitors | |
| IL275457A (en) | Spiro exo-aza inhibitors of the MENIN-MLL interaction | |
| SG11202000714QA (en) | Tyk2 inhibitors and uses thereof | |
| IL304110A (en) | Keap1–nrf2 protein–protein interaction inhibitors | |
| IL291268A (en) | Human plasma kallikrein inhibitors | |
| EP3142679A4 (en) | Peptide inhibitors of bcr-abl oligomerization | |
| EP3405477C0 (en) | TRANSGLUTAMINASE INHIBITORS | |
| GB201521059D0 (en) | Inhibitors of metallo-beta-lactamases | |
| PL3313865T3 (pl) | Syntetyczne związki peptydowe i sposoby zastosowania | |
| GB201708457D0 (en) | Inhibitors of metallo-beta-lactamases | |
| ZA201704495B (en) | Formulation of mk2 inhibitor peptides | |
| IL251016A0 (en) | Enhanced sodium channeling peptide inhibitors | |
| GB201708451D0 (en) | Inhibitors of metallo-beta-lactamases | |
| EP3419994A4 (en) | PEPTIDINHIBITORS OF CALCIUM CHANNELS | |
| HK1242983A1 (en) | Improved peptide inhibitors of sodium channels | |
| GB201504211D0 (en) | Use of peptides |